Filing Details
- Accession Number:
- 0002007919-24-000047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-12 17:14:23
- Reporting Period:
- 2024-09-10
- Accepted Time:
- 2024-09-12 17:14:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
2007919 | Inhibrx Biosciences Inc. | INBX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612627 | Md Kristiina Vuori | C/O Inhibrx Biosciences, Inc. 11025 N. Torrey Pines Road, Suite 140 La Jolla CA 92037 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-09-10 | 179 | $15.00 | 7,319 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-09-11 | 6,457 | $15.07 | 13,776 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple transactions at prices ranging from $15.00 to $15.08, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.